Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Neurometrix Inc (NURO) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview as of [[ item.timeDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 5,030
  • Shares Outstanding, K 5,320
  • Annual Sales, $ 7,300 K
  • Annual Income, $ -9,190 K
  • 36-Month Beta 0.23
  • Price/Sales 0.69
  • Price/Book 0.65
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -10.34
  • Most Recent Earnings N/A on N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 0.15 on 03/28/07
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.88 +2.27%
on 12/02/16
1.38 -34.78%
on 11/21/16
-0.37 (-29.13%)
since 11/02/16
3-Month
0.88 +2.27%
on 12/02/16
1.66 -45.78%
on 09/22/16
-0.56 (-38.36%)
since 09/02/16
52-Week
0.88 +2.27%
on 12/02/16
2.96 -69.59%
on 12/29/15
-1.75 (-66.04%)
since 12/02/15

Most Recent Stories

More News
NeuroMetrix Receives CE Mark Certification for Quell Wearable Pain Relief Device

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that the CE (Conformite Europeenne) Certificate for Quell(R) has been received from TA deg V SA deg D Product Service GmbH, which is...

NeuroMetrix' Quell Device Makes Second Appearance at American Society of Regional Anesthesia's Annual Pain Medicine Meeting

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that Quell(R) Wearable Pain Relief Technology(TM) will be featured for the second year in a row at the American Society for Regional...

NeuroMetrix Reports DPNCheck Introduction at the Annual Meeting of the China Diabetes Society

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) today reported that DPNCheck(R), a diagnostic test for peripheral neuropathy, will be introduced at the 20th Scientific Meeting of the Chinese Diabetes...

NeuroMetrix Announces Promotion of Frank McGillin to Chief Commercial Officer

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that it has promoted Frank McGillin to Senior Vice President and Chief Commercial Officer. Mr. McGillin's most recent title was Senior...

NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Pain Relief Technology

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 9,474,898. The patent covers key technology that enables safe...

NeuroMetrix to Present at 2016 Sidoti Emerging Growth Convention

NeuroMetrix, Inc. (NASDAQ:NURO, NUROW) announced today that Shai N. Gozani, M.D., Ph.D., President and Chief Executive Officer of NeuroMetrix, is scheduled to speak at the 2016 Sidoti Emerging...

NeuroMetrix Reports Q3 2016 Financial Results

--New quarterly highs for Quell device shipments and electrode reorders

NeuroMetrix Announces Participation at the 2016 Partners Connected Health Symposium

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) reported today that it will be an active participant at the Connected Health Symposium on October 20-21 in Boston sponsored by Partners Healthcare....

NeuroMetrix, Inc. Announces Date for 2016 Third Quarter Financial Results Conference Call

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that it plans to issue its 2016 third quarter financial results before the opening of the market on Thursday, October 20, 2016. The...

NeuroMetrix Announces Participation in Discover Blue: New York City Bluetooth Event

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) reported today that it has been selected to showcase Quell(R) Wearable Pain Relief Technology(TM) at the Discover Blue: New York City event hosted...

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is in the Top 1%. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More

Business Summary

Neurometrix is a medical device company establishing a new standard of care through the design, development and sale of proprietary products used to diagnose neuropathies. Neuropathies are diseases of the peripheral nerves and parts of the spine that frequently are caused by or associated with diabetes,...

See More

Support & Resistance

2nd Resistance Point 0.98
1st Resistance Point 0.94
Last Price 0.90
1st Support Level 0.87
2nd Support Level 0.84

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.